<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01822197</url>
  </required_header>
  <id_info>
    <org_study_id>IRB13-00044</org_study_id>
    <nct_id>NCT01822197</nct_id>
  </id_info>
  <brief_title>Pilot Trial of Phototherapy for Acute Depression in Hospitalized Cystic Fibrosis Patients</brief_title>
  <acronym>PHOTO</acronym>
  <official_title>Pilot Trial of Phototherapy for Acute Depression in Hospitalized CF Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Nationwide Children's Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Nationwide Children's Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether bright light phototherapy can improve
      depressive symptoms in hospitalized patients with cystic fibrosis (CF) with subsequent
      effects on quality of life and illness recovery. It is hypothesized that phototherapy will
      improve depressive symptoms and decrease length of stay in depressed patients with CF who are
      hospitalized.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Adults and adolescent with CF who are admitted to the hospital for pulmonary exacerbations
      will be enrolled. Subjects will use a Sun Touch Plus light box that emits 10,000 lux at a
      minimum distance of 60-80 cm away upon first awakening. Light exposure will last for 30
      minutes each day over one week. Nursing staff will ensure compliance and a light sensor
      attached to the light box will measure use as well. There will not be a placebo during this
      pilot trial due to recruitment concerns for the sample size required for a single center
      placebo controlled trial. All light boxes will be sterilized between patient use. Vitamin D
      levels will be recorded at enrollment from routine clinical measurement. Light boxes do NOT
      emit UV light and have a negative ionizer.

      Depression Screening: Quick Inventory of Depressive Symptomatology self report and clinician
      administered survey (QIDS-SR and QIDS-C) will be administered at admission (day 0) and
      completion of light therapy (day 7) to look at changes in depressive symptoms. The QIDS
      assesses all the criterion symptom domains designated by the American Psychiatry Association
      Diagnostic and Statistical Manual of Mental Disorders - 4th edition (DSM-IV) to diagnose a
      major depressive episode. The QIDS is sensitive to change, with medications, psychotherapy,
      or somatic treatments, making it useful for research purposes. The psychometric properties of
      both the QIDS has been established in various study samples. Cronbach's alpha was 0.85
      (QIDS-C16) and 0.86 (QIDS-SR16) in a reliability study by Triveldi in 2004.

      Quality of Life Scoring: The CF questionnaire revised (CFQ-R) will be administered
      simultaneously with the QIDS at days 0 &amp; 7 as a measure of health related quality of life
      (HRQOL). This is a well validated measure in the CF population for research studies (Riekert
      et al., 2007).
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>March 2013</start_date>
  <completion_date type="Actual">June 2015</completion_date>
  <primary_completion_date type="Actual">May 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Length of Hospitalization</measure>
    <time_frame>participants will be followed for the length of hospital stay, an average of 14 days</time_frame>
    <description>Length of stay will be measured in days</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Depressive Symptom Scores Post-Treatment (Day 7) and at Admission (Day 0)</measure>
    <time_frame>between day 0 and day 7 of hospitalization</time_frame>
    <description>depressive symptom scoring at day 0 and day 7 using Quick Inventory of Depressive Symptomatology-clinician (QIDS-C) and Quick Inventory of Depressive Symptomatology self-report (QIDS-SR). Day 7 and Day 0 scores will be compared. Score range is 0 to 27. A QIDS score of less than 6 indicates no depression, 6-10 indicates mild depression, 11-15 moderate, 16-20 severe, and 21- 27 very severe depression.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of Life Scoring Post-Treatment (Day 7) and at Admission (Day 0</measure>
    <time_frame>between day 0 and day 7 of hospitalization</time_frame>
    <description>Quality of life scoring at admission (Day 0) and post-treatment (Day 7) using the CF questionnaire-revised (CFQ-R) as a measure of health related quality of life. Minimally important changes in CFQ-R scoring have been reported at 5-8. Days 0 and 7 will be compared. Score range is 0 to 100. Lower scores indicate worse quality of life.</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">30</enrollment>
  <condition>Depression</condition>
  <condition>Cystic Fibrosis</condition>
  <arm_group>
    <arm_group_label>Phototherapy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Bright light phototherapy will be administered for 30 minutes daily over one week in the morning (Days 0-7)</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Phototherapy</intervention_name>
    <description>light will be administered at a minimum distance of 12 inches away to provide 10,000 lux</description>
    <arm_group_label>Phototherapy</arm_group_label>
    <other_name>Nature Bright Sun Touch Plus light box.</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with CF greater than 12 years of age

          -  Pulmonary exacerbation

        Exclusion Criteria:

          -  planned admission less than 24 hours

          -  suicidal ideation

          -  Bipolar depression

          -  known retinal disorder/photosensitivity

          -  light induced epilepsy or migraines

          -  age less than 12 years of age
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>12 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Benjamin T Kopp, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Nationwide Children's Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Nationwide Children's Hospital</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <zip>43205</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 25, 2013</study_first_submitted>
  <study_first_submitted_qc>March 27, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 2, 2013</study_first_posted>
  <results_first_submitted>July 25, 2016</results_first_submitted>
  <results_first_submitted_qc>July 25, 2016</results_first_submitted_qc>
  <results_first_posted type="Estimate">September 7, 2016</results_first_posted>
  <last_update_submitted>October 26, 2016</last_update_submitted>
  <last_update_submitted_qc>October 26, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 19, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Nationwide Children's Hospital</investigator_affiliation>
    <investigator_full_name>Benjamin Kopp</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Phototherapy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Depression</mesh_term>
    <mesh_term>Depressive Disorder</mesh_term>
    <mesh_term>Fibrosis</mesh_term>
    <mesh_term>Cystic Fibrosis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Phototherapy</title>
          <description>Bright light phototherapy will be administered for 30 minutes daily over one week in the morning (Days 0-7)
Phototherapy: light will be administered at a minimum distance of 12 inches away to provide 10,000 lux</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="30"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="30"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Phototherapy</title>
          <description>Bright light phototherapy will be administered for 30 minutes daily over one week in the morning (Days 0-7)
Phototherapy: light will be administered at a minimum distance of 12 inches away to provide 10,000 lux</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="30"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="30"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="27.7" spread="8.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="13"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="17"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="30"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Length of Hospitalization</title>
        <description>Length of stay will be measured in days</description>
        <time_frame>participants will be followed for the length of hospital stay, an average of 14 days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Phototherapy</title>
            <description>Bright light phototherapy will be administered for 30 minutes daily over one week in the morning (Days 0-7)
Phototherapy: light will be administered at a minimum distance of 12 inches away to provide 10,000 lux</description>
          </group>
        </group_list>
        <measure>
          <title>Length of Hospitalization</title>
          <description>Length of stay will be measured in days</description>
          <units>days</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="30"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="11" spread="3.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Depressive Symptom Scores Post-Treatment (Day 7) and at Admission (Day 0)</title>
        <description>depressive symptom scoring at day 0 and day 7 using Quick Inventory of Depressive Symptomatology-clinician (QIDS-C) and Quick Inventory of Depressive Symptomatology self-report (QIDS-SR). Day 7 and Day 0 scores will be compared. Score range is 0 to 27. A QIDS score of less than 6 indicates no depression, 6–10 indicates mild depression, 11–15 moderate, 16–20 severe, and 21– 27 very severe depression.</description>
        <time_frame>between day 0 and day 7 of hospitalization</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Phototherapy</title>
            <description>Bright light phototherapy will be administered for 30 minutes daily over one week in the morning (Days 0-7)
Phototherapy: light will be administered at a minimum distance of 12 inches away to provide 10,000 lux</description>
          </group>
        </group_list>
        <measure>
          <title>Depressive Symptom Scores Post-Treatment (Day 7) and at Admission (Day 0)</title>
          <description>depressive symptom scoring at day 0 and day 7 using Quick Inventory of Depressive Symptomatology-clinician (QIDS-C) and Quick Inventory of Depressive Symptomatology self-report (QIDS-SR). Day 7 and Day 0 scores will be compared. Score range is 0 to 27. A QIDS score of less than 6 indicates no depression, 6–10 indicates mild depression, 11–15 moderate, 16–20 severe, and 21– 27 very severe depression.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="30"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Post-treatment score</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.5" spread="2.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Admission score</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8.7" spread="3.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Quality of Life Scoring Post-Treatment (Day 7) and at Admission (Day 0</title>
        <description>Quality of life scoring at admission (Day 0) and post-treatment (Day 7) using the CF questionnaire-revised (CFQ-R) as a measure of health related quality of life. Minimally important changes in CFQ-R scoring have been reported at 5–8. Days 0 and 7 will be compared. Score range is 0 to 100. Lower scores indicate worse quality of life.</description>
        <time_frame>between day 0 and day 7 of hospitalization</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Phototherapy</title>
            <description>Bright light phototherapy will be administered for 30 minutes daily over one week in the morning (Days 0-7)
Phototherapy: light will be administered at a minimum distance of 12 inches away to provide 10,000 lux</description>
          </group>
        </group_list>
        <measure>
          <title>Quality of Life Scoring Post-Treatment (Day 7) and at Admission (Day 0</title>
          <description>Quality of life scoring at admission (Day 0) and post-treatment (Day 7) using the CF questionnaire-revised (CFQ-R) as a measure of health related quality of life. Minimally important changes in CFQ-R scoring have been reported at 5–8. Days 0 and 7 will be compared. Score range is 0 to 100. Lower scores indicate worse quality of life.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="30"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Pre-treatment Health Domain</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="35.5" spread="17.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Post-treatment health domain</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="59.7" spread="16.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Phototherapy</title>
          <description>Bright light phototherapy will be administered for 30 minutes daily over one week in the morning (Days 0-7)
Phototherapy: light will be administered at a minimum distance of 12 inches away to provide 10,000 lux</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="30"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="30"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr Ben Kopp</name_or_title>
      <organization>Nationwide Childrens Hospital</organization>
      <phone>6147224766</phone>
      <email>benjamin.kopp@nationwidechildrens.org</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

